Compare CNTY & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTY | ATRA |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.1M | 37.6M |
| IPO Year | N/A | N/A |
| Metric | CNTY | ATRA |
|---|---|---|
| Price | $1.50 | $4.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $3.67 | ★ $6.00 |
| AVG Volume (30 Days) | 38.8K | ★ 197.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $7.18 | N/A |
| P/E Ratio | ★ N/A | $2.28 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $4.20 |
| 52 Week High | $3.26 | $19.15 |
| Indicator | CNTY | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 29.45 |
| Support Level | $1.48 | $4.37 |
| Resistance Level | $1.53 | $5.11 |
| Average True Range (ATR) | 0.05 | 0.35 |
| MACD | -0.01 | 0.33 |
| Stochastic Oscillator | 14.41 | 10.03 |
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).